Has Seyed Shobeiri, MD received payments from drug or device companies?

Yes. Drug and device makers reported $116,460 in general payments to Seyed Shobeiri, MD across 131 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Seyed Shobeiri, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Seyed Shobeiri, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Seyed Shobeiri, MD

Urogynecology and Reconstructive Pelvic Surgery · Falls Church, VANPI 1477521110

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $81,502 of the $116,460 with a category attached, or 70.0%. Momentis Surgical Inc. accounts for 78.6% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2022 at $72,191 and has fallen 82.5% since, to $12,619 in 2025. Among urogynecology and reconstructive pelvic surgery clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$116,460in general payments, 2019–2025

Across 131 payments — averaging $889.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Momentis Surgical Inc.$92K
Femselect Inc.$13K
Ferring Pharmaceuticals Inc.$6K
Intuitive Surgical$4K
BK Medical Holding Company Inc.$1K
Applied Medical Resources Corporation$753
plus $864 from 6 others

$84,144in research payments, 2019–2025

Across 22 payments — averaging $3824.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Pacira Pharmaceuticals Incorporated$33K
Acessa Health Inc.$29K
Bayer$14K
Femselect Inc.$7K
Cook Research Incorporated$1K

What the payments were for

Consulting fees$81,50270%
Speaking & faculty fees$1,1251%
Travel & lodging$29,74926%
Food & beverage$1,5381%
Education$2,5462%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Momentis Surgical Inc.	105	$91,530
Femselect Inc.	4	$12,974
Ferring Pharmaceuticals Inc.	3	$5,547
Intuitive Surgical	8	$3,667
BK Medical Holding Company Inc.	1	$1,125
Applied Medical Resources Corporation	2	$753
Renovia Inc	2	$289
Axonics, Inc.	2	$159
Coloplast	1	$122
Medtronic	1	$116
AbbVie	1	$108
Caldera Medical, Inc	1	$71

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Anovo Surgical System$84,208
NEUGUIDE$12,974
Hominis Surgical System$6,750
NOCDURNA$5,547
Da Vinci Surgical System$3,497
bk3000, bk3500 & bk5000 Ultrasound System$1,125
GELPOINT VPATH$753
Leva Pelvic Floor Trainer$289
ALTIS$122
INTERSTIM$116
Axonics$112
BOTOX$108

How this compares

$116,460 in reported general payments places this provider in the 95th percentile of 29 urogynecology and reconstructive pelvic surgery providers in Virginia.

See all urogynecology and reconstructive pelvic surgery providers in Virginia →

Medicare billing

Part B allowed, 2024

$34,871

Medicare patients

Services billed

548

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Estradiol	18	$1,090
Oxybutynin Chloride ErOxybutynin Chloride	11	$58

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in Falls Church

Kurt McCammonVirginia Beach$67K
Jeffrey WelgossAnnandale$50K
Nathan GueretteMidlothian$20K
Eric ChangStafford$11K
Patricia MwesigwaArlington$8K
Anna TrikhachevaPortsmouth$6K
Walter von PechmannAnnandale$6K
Mary BurnsViriginia Beach$6K
Meghana GowdaRichmond$5K
Nina DereskaRoanoke$5K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →